Tom Isett established i.e. Advising in 2015 to support bioprocess organizations with strategy and management insights, and he has advised clients on over $20B in M&A transactions. In addition to having been Head of Cell Processing Technologies for Lonza, he was the founding VP of BD Advanced Bioprocessing and the founder of Commence Bio, a cellular immunotherapy innovator. Mr. Isett received his B.Sc. in biological sciences from Drexel University.
.svg)
